AzTrials
AzTrials

Tracheal IntubationNCT05160207

Intubation-induced Decrease in Heart Rate as an Indicator for Intraoperative Bradycardia

An observational study of Tracheal Intubation and Airway Management, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective observational study aims to determine, if an tracheal intubation-related decrease in heart rate is associated with intraoperative reflex bradycardia in patients undergoing microlaryngoscopy (MLS) in general anesthesia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tracheal Intubation, Airway Management, Heart Rate
How many people
50 participants
Where
1 siteGermany
Study dates
4 Nov 2021to 13 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients requiring general anesthesia with tracheal intubation for elective MLS in a tertiary care hospital who consent to participate within the study period.

Who may be able to join

  • Patients requiring general anesthesia with tracheal intubation for elective MLS
  • Age ≥ 18

Who cannot join

  • Pregnant or breastfeeding women
  • Confirmed indications for awake fiberoptic intubation
  • Planned endotracheal intubation without deep anesthesia or neuromuscular blocking agents (e.g. awake videolaryngoscopy)
  • Patients at risk for pulmonary aspiration who qualify for rapid sequence induction
  • Cardiac pacemaker
  • Atrial fibrillation
  • Denial of consent

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Medical Center Hamburg-Eppendorf

    Hamburg, 20246

Other trials in Germany

About this study

Official title: Tracheal Intubation-induced Decrease in Heart Rate as an Indicator for Intraoperative Bradycardia During Microlaryngoscopy -a Prospective Observational Trial

This prospective observational study aims to determine, if an tracheal intubation-related decrease in heart rate is associated with intraoperative reflex bradycardia in patients undergoing microlaryngoscopy (MLS) in general anesthesia.

Read the detailed description

Small studies and case series reported precipitous bradycardia or even asystole due to reflex vagal activity during tracheal intubation and/or laryngoscopy attributable to a so called laryngocardiac reflex (reflex bradycardia); however, larger systematic trials are still lacking. For the purpose of MLS, ENT surgeons frequently apply suspension laryngoscopy (Kleinsasser laryngoscope) in order to visualize the glottis and to enable surgery. Severe bradycardia has been reported during MLS that has been suspected to be induced by reflex vagal activity possibly promoted by the superior laryngeal nerve.

It is still unknown, which patients are at risk for relevant intraoperative bradycardia and moreover, which patients might benefit from preemptive measures such as prophylactic application of positive chronotropic drugs like atropine sulfate, epinephrine or glycopyrrolate. Predictive factors for MLS-induced intraoperative bradycardia have not systematically been investigated yet.

In particularly, it is unknown, if patients that present with a preoperative tracheal intubation-related decrease in heart rate have a predisposition for intraoperative reflex bradycardia during MLS.

This prospective observational study aims to determine, if an tracheal intubation-related decrease in heart rate is associated with intraoperative reflex bradycardia in patients undergoing microlaryngoscopy (MLS) in general anesthesia. Moreover, if we find a positive association, we further aim to determine the predictive value of intubation-relatd bradycardia.

Keywords
Laryngoscopy, Bradycardia, Microlaryngoscopy
Medical subject headings
Bradycardia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intraoperative decrease of the heart rate

    Continuous intraoperative ECG heart rate measurement (sample rate 1000 hz)

    Measured: 1 hour

Secondary outcomes (8)
  1. Intraoperative asystolia

    Continuous intraoperative ECG QRS-complex detection (sample rate 1000 hz)

    Measured: 1 hour

  2. Application of atropine sulfate

    Intraoperative application of atropine sulfate by the responsible anesthetist (yes/no)

    Measured: 1 hour

  3. Application of positive inotropic drugs

    Intraoperative application of other positive inotropic drugs such as epinephrine by responsible anesthetist (yes/no)

    Measured: 1 hour

  4. Cardiac arrhythmias

    Continuous intraoperative ECG arrhythmia detection and labeling (sample rate 1000 hz)

    Measured: 1 hour

  5. Hypotension

    Intraoperative blood pressure measurement

    Measured: 1 hour

  6. Application of catecholamines or vasoactive drugs

    Intraoperative application of catecholamines or vasoactive drugs by responsible anesthetist (yes/no)

    Measured: 1 hour

  7. Adverse cardiocirulatory events

    Intraoperative adverse cardiocirulatory events docuimented by the responsible anethetist

    Measured: 1 hour

  8. PACU stay

    Length of stay in the postanesthesia care unit (PACU)

    Measured: 8 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2021
  2. Study start4 Nov 2021
  3. Primary completion13 Jun 2022
  4. Study completion13 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05160207
Sponsor's protocol ID
2021-10378-BO-ff
Status last verified
Jul 2023
First submitted
5 Nov 2021
Last updated
19 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Tracheal Intubation and Airway Management, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intraoperative decrease of the heart rate (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in